GlassScriptPhysician profile
Shannon L Manning
NPI 1205421427
$2,290.78
in general payments reported to CMS, 2019-2025
21 companies · $568 in 2025
The $568 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $117 · 2022: $299 · 2023: $922 · 2024: $385 · 2025: $568.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,875.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,875.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $467.69 | 2022-2024 | Fintepla, Briviact |
| Abbvie INC. | $272.27 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $239.27 | 2025 | |
| Acadia Pharmaceuticals INC | $212.12 | 2023-2024 | Daybue |
| Corium, LLC | $166.32 | 2025 | Azstarys |
| Merz Pharmaceuticals, LLC | $137.89 | 2022-2023 | Xeomin |
| Neurelis, INC. | $136.85 | 2021-2024 | Valtoco |
| Jazz Pharmaceuticals INC. | $106.30 | 2022-2023 | |
| Genentech USA, INC. | $89.48 | 2022-2024 | Evrysdi |
| Livanova USA, INC. | $72.87 | 2023-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Eisai INC. | $71.72 | 2022-2023 | |
| Ns Pharma, INC. | $67.73 | 2024-2025 | Viltepso |
| Catalyst Pharmaceuticals, INC. | $65.86 | 2023-2024 | Fycompa |
| Immedica Pharma US, INC. | $33.75 | 2023 | |
| Medtronic, INC. | $30.62 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pyros Pharmaceuticals, INC. | $23.36 | 2024 | Vigpoder |
| Biocodex, INC. | $23.13 | 2024 | |
| Zogenix INC. | $21.33 | 2021 | |
| Tris Pharma INC | $20.11 | 2025 | Dyanavel Xr |
| Biomarin Pharmaceutical INC. | $16.26 | 2022 | |
| Amneal Pharmaceuticals LLC | $15.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shannon Manning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.